The Leadership Team at Gennao Bio is responsible for strategic decision-making and guiding the company’s vision in developing innovative genetic medicines. Comprising co-founders and key executives, the team focuses on advancing the proprietary GMAB platform technology, driving research and development, securing funding, and fostering partnerships to bring targeted nucleic acid therapeutics to market. Their collaborative efforts ensure that the company remains at the forefront of genetic medicine innovation.
View all